Skip to main content
Fig. 4 | World Journal of Surgical Oncology

Fig. 4

From: Upregulation of miR-1825 inhibits the progression of glioblastoma by suppressing CDK14 though Wnt/β-catenin signaling pathway

Fig. 4

Negatively regulation of CDK14 by miR-1825. a Predicted binding site between miR-1825 and 3′-UTR of CDK14. b Luciferase activity in A172 cells transfected with WT or MuT CDK14 and miR-1825 mimic or con mimic. c Decreased CDK14 level by miR-1825 mimic and increased CDK14 level by miR-1825 inhibitor. d Decreased CDK14 mRNA expression by miR-1825 mimic and increased CDK14 mRNA expression by miR-1825 inhibitor. e Negatively relationship between CDK14 and miR-1825 in GBM tissue (r = −0.7550, P < 0.0001). **P < 0.01

Back to article page